about
Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted miceToxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptorsInvestigation of human exposure to triclocarban after showering and preliminary evaluation of its biological effectsThe soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activityStructure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysisLipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolaseImpact of soluble epoxide hydrolase and epoxyeicosanoids on human healthThe molecular structure of epoxide hydrolase B from Mycobacterium tuberculosis and its complex with a urea-based inhibitorCrystal structure of the cystic fibrosis transmembrane conductance regulator inhibitory factor Cif reveals novel active-site features of an epoxide hydrolase virulence factorAutoantibody response to microsomal epoxide hydrolase in hepatitis C and ASynthesis and structure–activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitorsInhibition of soluble epoxide hydrolase by fulvestrant and sulfoxidesOptimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacyEpoxide hydrolases: their roles and interactions with lipid metabolismEpoxide hydrolases: mechanisms, inhibitor designs, and biological rolesEffect of soluble epoxide hydrolase polymorphism on substrate and inhibitor selectivity and dimer formationSoluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitorSoluble epoxide hydrolase: a novel therapeutic target in strokeDevelopment of fluorescent substrates for microsomal epoxide hydrolase and application to inhibition studiesPharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammationAlteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolaseNovel and highly sensitive fluorescent assay for leucine aminopeptidasesInhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine modelInhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammationPharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in ratsDevelopment of an HTS assay for EPHX2 phosphatase activity and screening of nontargeted librariesExpression and regulation of soluble epoxide hydrolase in adipose tissueRedox regulation of soluble epoxide hydrolase by 15-deoxy-delta-prostaglandin J2 controls coronary hypoxic vasodilationPeripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptivePharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogsAberrant soluble epoxide hydrolase and oxylipin levels in a porcine arteriovenous graft stenosis model
P50
Q23910189-B94D67E5-E4E8-4139-909B-B9B7BA45A48DQ23911122-DC99946D-F65A-4557-9DA5-D67B68FF0B53Q23918896-714F6BFB-F842-487C-A1F3-499B14121B4BQ24294384-1FA28FF5-E45D-401F-965A-906183BEDC6BQ24337287-E80085A2-DADC-47F2-9982-5AEAB06A07E4Q24546215-9E6AF44B-D66D-4D05-A006-EC2EBF3C38F6Q24618018-C54E6253-8776-47B0-9EB9-537DF495118DQ24625809-E257A618-2927-4462-A100-44743C7664F3Q24629214-F0C3100D-B860-42E0-B310-B7C752F7E5DFQ27480290-8497294B-9395-4B8D-A55A-77FDF36180FCQ27675485-F2DA681D-0A62-424D-9A9D-F0723AC77CB8Q27678172-3D2EE705-6570-4F3C-BCB9-F68C934ADDE8Q27684895-F6F8F333-CCE5-4979-9C27-5A32C901D15AQ28238075-753AE34B-7FFB-45E4-BE04-0D7F33B3B489Q28244409-10CA9D45-221B-4673-88E4-F996F744DCAFQ28386561-1A054544-79C2-4EDE-B6A9-3C01BD42E81CQ28387686-03DEC4A4-43EE-436E-B7BB-0583DEB711ECQ28388145-0149270A-D733-47CB-B966-3EF92742FBD7Q28388362-56E5C120-86F2-4C23-9DC0-687847BFA2C5Q28389323-7E172CA6-DAE6-427A-ADD3-C6F6A5737309Q28390217-DB466789-C958-4844-A435-97183E1A4615Q28391133-78D5AC96-E393-4673-858D-57D50E5ED3F5Q28391172-0924E770-CC30-466D-BC70-F0AB8607B607Q28391533-227C8F7A-1CC4-4836-87DC-728806C83E60Q28392609-27166AF2-94F7-4262-A505-847CBDC00604Q28393751-D38970FA-D2F4-40CC-AE65-908D1FD44B93Q28395245-A8BDFFB9-C752-42B9-B159-68CC7063AFC2Q28395654-04B7CBB7-421B-46F9-B871-508CE545A73CQ28396233-62C81F27-C44A-4BD1-89E3-9C6AC173B52CQ28396888-A0B5F37B-5C07-4A3E-AE1C-15C0A9AC4C9EQ28397805-EBF98F11-E56C-47E4-8966-8571237A0215
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Christophe Morisseau
@ast
Christophe Morisseau
@en
Christophe Morisseau
@es
Christophe Morisseau
@nl
Christophe Morisseau
@sl
type
label
Christophe Morisseau
@ast
Christophe Morisseau
@en
Christophe Morisseau
@es
Christophe Morisseau
@nl
Christophe Morisseau
@sl
prefLabel
Christophe Morisseau
@ast
Christophe Morisseau
@en
Christophe Morisseau
@es
Christophe Morisseau
@nl
Christophe Morisseau
@sl